Evidence map›Paper›PMID 39636222›Full record

ArticleCancer research communications2025

Autofluorescence Virtual Staining System for H&E Histology and Multiplex Immunofluorescence Applied to Immuno-Oncology Biomarkers in Lung Cancer.

Jessica Loo, Marc Robbins, Carson McNeil, Tadayuki Yoshitake, Charles Santori, Chuanhe Jay Shan, Saurabh Vyawahare, Hardik Patel, Tzu Chien Wang, Robert Findlater and 18 more

Abstract read
In one paragraph

Article in Cancer research communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Jessica Loo *Verily, South San Francisco, California.ORCID 0000-0002-5484-9339
Marc Robbins *Verily, South San Francisco, California.ORCID 0009-0007-9457-4898
Carson McNeilVerily, South San Francisco, California.ORCID 0009-0002-7917-3635
Tadayuki YoshitakeVerily, South San Francisco, California.ORCID 0000-0003-4156-6484
Charles SantoriVerily, South San Francisco, California.ORCID 0009-0003-0758-1776
Chuanhe Jay ShanVerily, South San Francisco, California.ORCID 0009-0007-2378-8178
Saurabh VyawahareVerily, South San Francisco, California.ORCID 0000-0002-6162-3768
Hardik PatelVerily, South San Francisco, California.ORCID 0000-0003-3819-4691
Tzu Chien WangVerily, South San Francisco, California.ORCID 0009-0008-2832-090X
Robert FindlaterVerily, South San Francisco, California.ORCID 0009-0009-1568-4912
David F SteinerGoogle, Mountain View, California.ORCID 0000-0003-1297-0023
Sudha RaoVerily, South San Francisco, California.ORCID 0009-0002-2074-1124
Michael GutierrezVerily, South San Francisco, California.ORCID 0000-0002-7054-2310
Yang WangVerily, South San Francisco, California.ORCID 0009-0001-3470-9363
Adrian C SanchezVerily, South San Francisco, California.ORCID 0009-0000-8791-0661
Raymund YinVerily, South San Francisco, California.ORCID 0000-0002-3001-6471
Vanessa VelezVerily, South San Francisco, California.ORCID 0009-0004-3287-7314
Julia S SigmanVerily, South San Francisco, California.ORCID 0009-0006-2845-5543
Patricia Coutinho de SouzaGenmab, Princeton, New Jersey.ORCID 0009-0004-6124-3214
Hareesh ChandrupatlaGenmab, Princeton, New Jersey.ORCID 0000-0002-0470-5492
Liam ScottGenmab, Princeton, New Jersey.ORCID 0000-0002-6114-6324
Shamira S WeaverVerily, South San Francisco, California.ORCID 0009-0007-6158-6294
Chung-Wein LeeGenmab, Princeton, New Jersey.ORCID 0000-0001-8185-9762
Ehud RivlinVerily, South San Francisco, California.ORCID 0009-0008-6432-9127
Roman GoldenbergVerily, South San Francisco, California.ORCID 0000-0002-5538-772X
Suzana S CoutoGenmab, Princeton, New Jersey.ORCID 0000-0001-6932-5442
Peter CimermancicVerily, South San Francisco, California.ORCID 0000-0002-2802-7649
Pok Fai WongVerily, South San Francisco, California.ORCID 0009-0008-4283-662X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractVirtual staining for digital pathology has great potential to enable spatial biology research, improve efficiency and reliability in the clinical workflow, as well as conserve tissue samples in a nondestructive manner. In this study, we demonstrate the feasibility of generating virtual stains for hematoxylin and eosin (H&E) and a multiplex immunofluorescence (mIF) immuno-oncology panel (DAPI, PanCK, PD-L1, CD3, and CD8) from autofluorescence (AF) images of unstained non–small cell lung cancer tissue by combining high-throughput hyperspectral fluorescence microscopy and machine learning. Using domain-specific computational methods, we evaluated the accuracy of virtual H&E staining for histologic subtyping and virtual mIF for cell segmentation–based measurements, including clinically relevant measurements such as tumor area, T-cell density, and PD-L1 expression (tumor proportion score and combined positive score). The virtual stains reproduce key morphologic features and protein biomarker expressions at both tissue and cell levels compared with real stains, enable the identification of key immune phenotypes important for immuno-oncology, and show moderate to good performance across various evaluation metrics. This study extends our previous work on virtual staining from AF in liver disease and prostate cancer, further demonstrating the generalizability of this deep learning technique to a different disease (lung cancer) and stain modality (mIF). SIGNIFICANCE: We extend the capabilities of virtual staining from AF to a different disease and stain modality. Our work includes newly developed virtual stains for H&E and a multiplex immunofluorescence panel (DAPI, PanCK, PD-L1, CD3, and CD8) for non-small cell lung cancer, which reproduce the key features of real stains.

Indexed as

Biomarkers, TumorCarcinoma, Non-Small-Cell LungFluorescent Antibody TechniqueLung NeoplasmsHumansOptical ImagingStaining and LabelingBiomarkers, Tumor

Identifiers

PMID39636222
PMCPMC11707747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.